• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION, INC 25GX3.5IN WHIT 5ML GLASPAK BUPI CLEAR; N/A

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION, INC 25GX3.5IN WHIT 5ML GLASPAK BUPI CLEAR; N/A Back to Search Results
Catalog Number 400866
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Pain (1994); Inadequate Pain Relief (2388)
Event Date 10/01/2019
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that 25gx3.5in whit 5ml glaspak bupi clear was used and the anesthesia was ineffective.This was discovered during use.The following information was provided by the initial reporter: material no.: 400866, batch no.: 1280749.It was reported that during a spinal procedure involving a spinal syringe the patient was feeling pain due to a possible issue with the effectiveness of the meds in the tray.
 
Event Description
It was reported that 25gx3.5in whit 5ml glaspak bupi clear was used and the anesthesia was ineffective.This was discovered during use.The following information was provided by the initial reporter: material no.: 400866 batch no.: 1280749 it was reported that during a spinal procedure involving a spinal syringe the patient was feeling pain due to a possible issue with the effectiveness of the meds in the tray.
 
Manufacturer Narrative
H.6.Investigation summary three physical samples were provided for evaluation by our quality engineer team.Each of the provided samples was visually inspected; however, no defects were observed.The liquid within each drug vial was found to be clear without any signs of visible particulate matter.A device history record review was performed for the provided lot number and the review did not reveal any detected abnormalities during the production process.A review of the temperature monitoring system within the manufacturing facility did not identify any excursions that would have negatively affected the raw material drug components used in this product.Based on the investigation results, a definitive cause for this incident could not be identified.Our vendor has been made aware of this incident and our quality team will continue to monitor the production process for this defect.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
25GX3.5IN WHIT 5ML GLASPAK BUPI CLEAR
Type of Device
N/A
Manufacturer (Section D)
CAREFUSION, INC
400 east foster rd
mannford OK 74044
MDR Report Key9251339
MDR Text Key195566576
Report Number1625685-2019-00122
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 01/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2021
Device Catalogue Number400866
Device Lot Number0001280749
Date Manufacturer Received10/14/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age78 YR
Patient Weight74
-
-